
Boss of huge car firm warns brands are ‘heading full speed into a wall' and could ‘collapse' over EVs
CHARGED UP Boss of huge car firm warns brands are 'heading full speed into a wall' and could 'collapse' over EVs
EUROPE'S car industry is 'heading at full speed against a wall', the boss of a huge car firm has warned.
In a stark intervention, Mercedes-Benz boss Ola Källenius said the industry risks collapsing if the EU doesn't rethink its ban on new petrol and diesel cars
Advertisement
3
Mercedes-Benz boss Ola Källenius says a 'reality check' is needed before the 2035 ban on combustion-engine sales is locked in
Credit: AFP
3
Europe's car industry is 'heading at full speed against a wall' and risks collapsing if EU doesn't rethink ban on petrol and diesel cars, says boss
Credit: AFP
3
Electric cars remain far from dominating the market, with EVs making up just 17.5 per cent of sales across the EU in the first half of this year
Credit: EPA
He also said a 'reality check' was needed before the 2035 ban on combustion-engine sales is locked in.
Mr Källenius told German business paper Handelsblatt: "We need a reality check. Otherwise, we are heading at full speed against a wall.
"Of course, we have to decarbonise, but it has to be done in a technology-neutral way. We must not lose sight of our economy."
The luxury brand — once gung-ho about going fully electric in Europe — has already dropped its ambitious 2021 pledge to stop selling combustion cars 'where market conditions allow' by the decade's end.
Advertisement
Källenius, who also heads the European Automobile Manufacturers' Association (ACEA), now warns the EU's policy could trigger a last-minute rush for petrol and diesel cars before the cut-off, which 'doesn't help the climate at all.'
Electric cars remain far from dominating the market.
In the first half of this year, EVs made up just 17.5 per cent of sales across the EU, UK, and EFTA countries, while plug-in hybrids took 8.7 per cent.
Traditional hybrids accounted for 35 per cent, but that figure includes mild-hybrids, which critics say aren't 'true' hybrids.
Advertisement
Mercedes' own figures show EV sales slipping — just 8.4 per cent of its global deliveries in the first six months of 2025, down from 9.7 per cent last year.
Even with plug-ins included, electrified models made up just 20.1 per cent of shipments.
Tesla's Cybertruck Graveyard: Hundreds of Unsold EVs Abandoned at Shopping Mall
The EU's 2035 ban is due for review in the coming months, but Brussels has so far signalled no U-turn, reiterating in March its commitment to zero-emission new cars by the mid-2030s.
It comes as the boss of Stellantis — the giant behind 14 brands including Fiat, Peugeot, and Maserati — warned that unreachable EU CO2 targets could force plant closures.
Advertisement
Europe chief Jean-Philippe Imparato said the Franco-Italian group faces fines of up to €2.5 billion within 'two-three years' if it fails to meet emissions rules.
Without a regulatory rethink by year-end, 'we will have to make tough decisions,' he told a conference in Rome.
'I have two solutions: either I push like hell (on electric)… or I close down ICE (internal combustion engine vehicles).
And therefore I close down factories,' he said, pointing to the risk for sites such as Stellantis' van plant in Atessa, Italy.
Advertisement
The warning comes amid fresh turmoil for Stellantis, with its new CEO Antonio Filosa inheriting the fallout from Donald Trump's 25 per cent US import tariffs and a crisis at Maserati, which has seen sales plunge from 26,600 in 2023 to 11,300 last year.
With EV targets biting, petrol and diesel models under threat, and luxury brands cancelling investments — including Maserati's £1.3bn electric MC20 Folgore — Europe's car bosses are sending a clear signal to Brussels: ease off, or risk slamming the brakes on the continent's auto industry.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


RTÉ News
2 hours ago
- RTÉ News
Valentino CEO steps down for personal reasons
Valentino CEO Jacopo Venturini has stepped down, the Italian luxury house said today, leaving the Mayhoola- and Kering-backed business searching for a new leader to reboot sales and profit. Valentino reached a mutual agreement with Mr Venturini to terminate his employment and board roles effective Wednesday as he "has decided to take a break for personal reasons", the brand said in an announcement seen by news agency Reuters. Mr Venturini, previously executive vice president of merchandising at Gucci, became CEO at Valentino in June 2020. Valentino had said in June that he was on sick leave, after media reports of his imminent departure from the business which reported declining revenue and profit last year. Valentino, founded in Rome in 1960 by Valentino Garavani and Giancarlo Giammetti, is part-owned by French luxury conglomerate Kering, which bought a 30% stake in the label from Qatari fund Mayhoola for €1.7 billion in 2023, with a commitment to buy the rest by 2028. Mayhoola and Kering did not reply to Reuters requests for comment about Mr Venturini's departure.


The Irish Sun
3 hours ago
- The Irish Sun
Lewis Hamilton's billionaire former boss reveals unusual eating habits including having same meal twice every day
YOU would expect billionaire Mercedes boss Toto Wolff to lead a lavish lifestyle when it comes to food. But the F1 chief likes to keep things simple with the exact same meal for both lunch and dinner. 1 Toto Wolff has the exact same meal for lunch and dinner Credit: Shutterstock Editorial Wolff has overseen Merc's glittering run of eight consecutive Constructors' Championships from 2014 to 2021 as well as six of Lewis Hamilton's driver's titles. Advertisement The 53-year-old Austrian boss says he avoids distractions by eating the same dish twice a day with him often on the road. During his appearance on Desert Island Discs, he explained: "For me it is really reducing trivial things. "I'm wearing the same clothes, I'm eating the same food - even to the point that my assistants book the same hotel room for me every single year." Curiosity peaked when Wolff was quizzed about his preferred dish for breakfast, to which he replied: "The same dark bread - a pumpernickel with butter and some ham. Advertisement He then delved into more detail on his coffee drinking habits and the two same meals he has to follow. He added: "Small cappuccino - because I take half a cappuccino because I want to have another half an hour later - and then it's chicken breast with tomato salad. And I have the same for dinner also!" Wolff could do without any distractions this season with Mercedes struggling to really make their mark. BEST ONLINE CASINOS - TOP SITES IN THE UK Advertisement George Russell and Kimi Anontelli are both out of contract at the end of the year. British 27-year-old Russell is reportedly on the brink of signing a new £30m-a-year deal. Ultimate F1 team principal's rich list including Red Bull's Christian Horner and Mercedes boss Toto Wolff Play Dream Team now! Play The Sun Dream Team ahead of the 2025/26 season Free to play Over £100,000 in total prize money Play in Mini Leagues against your mates Submit a team for Gameweek 1 to enter £5,000 prize draw Play via Dream Team's app or website today! Wolff was pictured this week on a yacht off the coast of Sardinia, laughing and joking with four-time world champion Max Verstappen. The Dutchman is set to stay put at Red Bull next season, but he could be on the move if his team continue to struggle.


Irish Times
6 hours ago
- Irish Times
From pharma to food, the known unknowns of Trump's EU tariffs deal
The US/ EU tariff deal was meant to bring certainty for exporters. But almost three weeks later there is a lot that we don't know – and more that remains uncertain. A joint statement signed off by both sides had been expected shortly after the big summit in Scotland at the end of July , clarifying key parts of the deal and how it would be implemented. But this week, a European Commission spokesperson said, in best bureacrateese, that while further contacts with the US were expected on this, 'I don't believe at this stage we can put a timeline on these engagements.' 1. What is covered by the new tariffs? The deal had been hailed as bringing 'certainty' to Irish exporters. And it has done so, but only up to a point. A blanket 15 per cent tariff now applies on most categories or exports from Ireland to the US. READ MORE As ever with trade, there are tweaks. Some goods which had been subject to previous higher tariff charges (under the most favoured nation or MFN system) will still pay these. For Ireland, the main product affected here is butter – with Kerrygold now the second biggest seller on the US market. Before Trump came to office it had been levied at a rate based on weight – rather than the more usual percentage calculation. However, this worked out at somewhere over 16 per cent in practice. So this slightly higher rate will remain. Other sectors face tariffs for the first time, or higher charges. For example, the large medical products sector had previously been largely exempted, but is now being levied at 15 per cent. So are parts of the food sector and spirits. 2. What is not covered? US customs has published a list of goods that are excluded from the 15 per cent tariff and Carol Lynch, customs partner at BDO, says this is a good place for SMEs unsure if they are covered to check. A key point for Ireland is that pharma products, by far the State's biggest in value terms, are not currently subject to the 15 per cent tariff. This may change, as the Trump administration is undertaking a study of pharma supply into the US market and the national security issues that apply – the so-called section 232 investigation which refers back to a 1960s act of congress. This is the backdrop to Trump's talk of 150 per cent or 250 per cent tariffs on pharma in 18 months or two years' time, applying to companies that do not play ball and return production to the US market. The EU believes the US has signed up to a 15 per cent cap on pharma – and semiconductor – tariffs under the deal, but Trump's subsequent statements suggest otherwise. This is why the absence of a joint agreed statement between the EU and US is important. 3. What might change? Another frustration for the EU is that the outline agreement suggested that more areas would be excluded from the 15 per cent tariff net but, beyond aircraft and aircraft parts, none of these has yet been spelt out. These 'carveouts' were due to cover some areas of food of potential interest to Ireland, some generic drugs and chemicals and perhaps medical devices, a sector which typically has lower margins and fixed price contracts with US buyers. The EU had also been pushing for a 'zero for zero' tariff deal on wines and spirits, though the indications were the US was unlikely to concede this. So bar the list published by US Customs, we are no wiser on what other sectors may, in time, get a pass. 4. What can companies do? The practical steps, according to Lynch of BDO, are, first, to check whether goods were in transit before August 7th, in which case the old 10 per cent rate would apply rather than the new 15 per cent. Companies need to know the tariff codes being used by those importing their products and whether any of the exclusions they know about so far apply. And, she says, they need to examine whether they have any flexibility under the rules in terms of the value of goods declared for customs purposes. This is a complex area with detailed pricing rules applying but, particularly in high value sectors like pharma, companies may have options to readjust supply changes or pricing policies to cut their tariff bills. 5. Where next on pharma? The Trump administration has been promising the results of its section 232 investigation shortly, expected by way of a big report. Alongside this, Trump's team have been negotiating on prices with the big US pharma companies, demanding that they charge the same prices in the US as other countries. A 2022 study showed that US prices were, on average, three times higher than the OECD average. This – in Trump's view- means prices should fall in the US and rise in other countries, thus giving the US consumer a better deal while giving companies ongoing revenue to fund research. It is unclear what the outcome of this will be but the two areas are linked. Imposing tariffs on imports risks increasing prices on the US market, the opposite of the goal of the price negotiations. The US president is threatening tariffs which would gradually increase over time as a way of getting big pharma to relocate more production to the US of key drugs and ingredients. So will we see 15 per cent pharma tariffs when the result of the Section 232 probes are out? Or will the US president hold off for now while holding out the threat of tariffs if big pharma does not fall into line on prices and investment? 6. Ireland's pharma exposure: In a post on the pharma issue on LinkedIn, Ben McConkey, an Irish MSc student at the London School of Economics, underlines the extent of Ireland's 'pharma' exposure by pointing out that the US imported over $50 billion worth of Irish pharmaceutical products in 2004, making it the single largest category of goods imported from any EU country by a margin of $15 billion and representing 8.3 per cent of all US imports from the EU. While the noise around the trade talks was about German cars, Irish pharma exports have a higher value, though this is of course hugely inflated by the pricing practices of the firms involved, which have a financial incentive to declare as much profit as possible in low tax Ireland. McConkey also makes the interesting point that the bulk of Irish pharma and organic chemicals go to republican states such as Indiana – home of Eli Lilly – as well as Puerto Rico, North Carolina and Illinois. Many are not finished drugs but are high value ingredients in drugs then sold across the US. As tariffs will have an economic impact on these companies – and on US consumers – it remains to be seen what the president decides. But the stakes for Ireland in the Section 232 process are huge as it could influence both future manufacturing investment and the transfer pricing structures the companies employ which led to huge profits being declared in Ireland and a lot of corporate tax being paid here. 7. The uncertainty may just roll on: The EU's belief was that a joint statement would be agreed with the US on the basis of the political agreement between Trump and European Commission president Ursula von der Leyen in Scotland. This would then be followed by further detailed negotiations. It is unclear if the absence of even a basic, joint written understanding is just a result of August holidays or whether it is a sign of the way the US president tends to operate – in headlines and in a way which leaves him with maximum flexibility to change tack. The president and his team have been continuing to push the boat out in terms of tariffs and pressure on US businesses to bend to their will. There is a fair chance that the uncertainty will roll on – and on. And this in itself will have a cost on businesses, even if the 15 per cent deal will have left many feeling they have some more solid ground on which to plan. And, it must be remembered that the US president's right to impose the 15 per cent tariffs at all is being challenged in the courts – a process likely to go right to the US supreme court for an ultimate decision.